MedMen Appoints New COO: Roz Lipsey Takes The Reins


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) announced Monday it has promoted Roz Lipsey to a chief operating officer, succeeding Tim Bossidy, who has served as an interim COO since 2020.

Lipsey has been part of the company's executive management team since 2020. Prior to the promotion, she served as senior vice president of business operations.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

With more than 25 years of operational experience, Lipsey's focus was on business start-ups, scaling and strategy.

Previously Lipsey served as president of a vertically integrated cannabis operation in Arizona, where she successfully scaled its cultivation, manufacturing, wholesale and retail businesses prior to its acquisition by MedMen.

She also held leadership positions at family investment office Jokake Companies, cotton company Volkart/Anderson Clayton and the Foreign Agricultural Service.

Tom Lynch, CEO of MedMen, said he is thrilled to promote Lipsey to a new role in the Los Angeles company.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


"During her time at MedMen, she has proven to be a sharp, results-driven leader with a deep understanding of our business and the inherent complexities of a fast-growing multi-state cannabis operation," Lynch said. "Her expertise and experience in this sector will be invaluable in this new phase of progress and momentum."

Bossidy will resume his role as a senior director at SierraConstellation Partners where he developed the cannabis practice and served in a number of interim management roles in cannabis and retail.

More recent news from MedMen:

MMNFF Price Action

MedMen's shares traded 2.59% lower at 26 cents per share at the time of writing Monday morning.

Photo: Courtesy of fauxels from Pexels


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: CannabisNewsPenny StocksMarketsRoz LipseyTom Lynch